Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5–6 in non‐addicted infants
Abstract
Objective The neonatal abstinence scoring system proposed by Finnegan is used widely in neonatal units to initiate and to guide therapy in babies of opiate‐dependent mothers. The purpose of this study was to assess the variability of the scores in newborns and infants not exposed to opiates during the first 3 days of life and during 3 consecutive days in weeks 5 or 6.Patients and methods Healthy neonates born after 34 completed weeks of gestation, whose parents denied opiate consumption and gave informed consent, were included in this observational study. Infants with signs or symptoms of disease or with feeding problems were excluded. A modified scoring system was used every 8 hours during 72 hours by trained nurses; 102 neonates were observed for the first 3 days of life and 26 neonates in weeks 5–6. A meconium sample and a urine sample at weeks 5–6 were stored from all infants to be analysed for drugs when the baby scored high. Given a non‐Gaussian distribution the scores were represented as percentiles.Results During the first 3 days of life median scores remained stable at 2 but the variability increased, with the 95th percentile rising from 5.5 on day 1 to 7 on day 2. At weeks 5–6 median values were higher during daytime (50th percentile = 5, 95th percentile = 8) than night‐time (50th percentile = 2, 95th percentile = 6, P = 0.02).Conclusion Scores increase from days 1–3 to weeks 5–6 and show day–night cycles with 5–6 weeks. Values above 8 can be considered pathological. This data may help to raise suspicion of narcotic withdrawal and to guide therapy.Keywords
This publication has 11 references indexed in Scilit:
- Benign neonatal sleep myoclonus in newborn infants of opioid dependent mothersActa Paediatrica, 2008
- Managing drug withdrawal in the newborn infantSeminars in Fetal and Neonatal Medicine, 2007
- Bioanalytical procedures for monitoring in utero drug exposureAnalytical and Bioanalytical Chemistry, 2007
- Management of neonatal abstinence syndrome in neonates born to opioid maintained womenDrug and Alcohol Dependence, 2007
- Determination of the prevalence of drug misuse by meconium analysisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2006
- Management of neonatal abstinence syndrome in neonatal intensive care units: a national surveyJournal of Perinatology, 2005
- The Neonatal Intensive Care Unit Network Neurobehavioral Scale ProceduresPediatrics, 2004
- The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-ReportPediatrics, 2001
- The Normal Crying Curve: What Do We Really Know?Developmental Medicine & Child Neurology, 1990
- Narcotic withdrawal symptoms in the newborn infant resulting from maternal addictionThe Journal of Pediatrics, 1958